AXGN
Axogen, Inc. Common StockRecent alerts on AXGN
All signals →
News
Bruker Stock Gains From Its Latest Acquisition of Dynamic Biosensors
14d ago
News
Owens & Minor Stock to Gain From New Collaboration With Google Cloud
14d ago
News
Intuitive Surgical (ISRG) Hits All-Time High: Will It Go Higher? - Zacks Investment Research
14d ago
News
AxoGen's (AXGN) New Launch to Aid Peripheral Nerve Protection
14d ago
News
Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?
14d ago
Insider trade
Sale by Amy Mcbride Wendell
20d ago
Insider trade
Sale by Doris Quackenbush (Sales VP)
24d ago
Insider trade
Sale by Kathy Johnson Weiler
24d ago
Insider trade
Sale by Jens Kemp (Chief Marketing Officer)
24d ago
Insider trade
Sale by Lindsey Marie Hartley (CFO)
24d ago
Insider trade
Sale by John Johnson
24d ago
News
Axogen outlines at least $270M 2026 revenue on at least 20% growth amid Avance biologic channel transition
34d ago
SEC filing
AXGN Reports $61.5M Q1 Rev, $19.6M Net Loss, $5.7M Adj. EBITDA, $133.3M Offering, $69.7M Loan Repay, 20% FY26 Rev Guidance
35d ago
Insider trade
Sale by Erick Wayne Devinney (Chief Innovation Officer)
75d ago
News
Earnings Preview: Ford’s Trucks, McDonald’s Value, and Ferrari’s Brand Test
112d ago
News
Axogen stock dips after pricing $124M offering
131d ago
News
Biggest stock movers Thursday: DDOG, BABA, and more
131d ago
News
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
131d ago
News
Axogen Announces Proposed Public Offering of Common Stock
131d ago
News
Axogen CEO Axed 25,000 Shares From His Direct Holdings
139d ago
News
Axogen sees Q4 net sales of up to $59.9M and FY2025 at $225.2M
141d ago
News
Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
141d ago
News
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
156d ago
Get push alerts for AXGN
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS